NDC 17856-0672-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0672
- Requested NDC
- 17856-0672-01
- Package NDCs from labels
- 17856-0672-1, 17856-0672-2, 17856-0672-3, 17856-0672-4, 17856-0672-01
- Manufacturer
- Atlantic Biologics Corp.
- Effective date
- 2025-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Atlantic Biologics Corp. | Atlantic Biologics Corp. | 2025-10-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0672-1 | Ondansetron | 60 in 1 CASE | SOLUTION | 60 | 1 | |
| 17856-0672-1 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-2 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-2 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-3 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-3 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-4 | Ondansetron | 72 in 1 CASE | SOLUTION | 72 | 1 | |
| 17856-0672-4 | Ondansetron | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0672-1 | ML - Milliliter | 17856-0672 | f5b97fd9-6050-46e6-b0da-693821d3938a | 1 | 2026-03-17 |
| 17856-0672-2 | ML - Milliliter | 17856-0672 | 787cc894-2cc2-4952-981c-f67609a087e3 | 1 | 2026-03-17 |
| 17856-0672-3 | ML - Milliliter | 17856-0672 | 53831650-5a50-4e31-9590-1c0ac60dc7ec | 1 | 2026-03-17 |
| 17856-0672-4 | ML - Milliliter | 17856-0672 | 68c3eadb-fcbb-40cc-80d0-0ddc4021b83a | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alka-Seltzer Extra Strength | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE, AND ASPIRIN | Bayer HealthCare LLC. | 49b73bd5-6465-05eb-e054-00144ff88e88 | 2025-12-04 | Warnings | XF417D3PSL |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | 5be36a7f-7d1f-468d-9c29-92c8cd3ef1bc | 2025-12-04 | Warnings | XF417D3PSL |
| Ondansetron | ONDANSETRON | Hospira, Inc. | e0862c02-781f-4b10-ae50-9c9c4ca26f6d | 2025-12-01 | Warnings, Adverse reactions | NMH84OZK2B |
| BUDDATE INONOTUS OBLIQUUS WATER BRILLIANCE MASK | BUTYLENE GLYCOL, GLYCERIN, INONOTUS OBLIQUUS (MUSHROOM) EXTRACT | BUDDATE Co Ltd | 464988ad-557e-13f5-e054-00144ff8d46c | 2025-11-30 | Warnings | PDC6A3C0OX |
| BUDDATE LOTUS MOISTURE ESSENCE | GLYCERIN, NIACINAMIDE, NELUMBO NUCIFERA FLOWER EXTRACT, PORTULACA OLERACEA EXTRACT | BUDDATE Co Ltd | 46499995-8b13-3e5c-e054-00144ff88e88 | 2025-11-30 | Warnings | PDC6A3C0OX |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | ab19b011-0a51-4f04-9881-d9fc7cae95ae | 2025-11-25 | XF417D3PSL | |
| Rain Daily Hydration and Comfort For Dry Eyes | GLYCERIN | Rain Eye Drops, LLC | 31d7c204-fb74-fb28-e063-6294a90ab330 | 2025-11-23 | Warnings | PDC6A3C0OX |
| Brain Liquescence | GINKGO BILOBA, COLCHICUM AUTUMNALE, CONVALLARIA MAJALIS, NUX MOSCHATA, CEREBRUM (SUIS), AGARICUS MUSCARIUS, SCUTELLARIA LATERIFLORA, ANACARDIUM ORIENTALE, RIBOFLAVINUM, AMBRA GRISEA, BARYTA CARBONICA, GLYCERINUM | Nutritional Specialties, Inc. | a5c366f3-fd42-4602-b20b-b7b15fde564e | 2025-11-19 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 804d7b1f-1be8-50c9-e053-2a91aa0a35d0 | 2025-11-18 | Warnings | PDC6A3C0OX |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | R J General Corporation | dbb0d067-71f0-45e4-bc98-548cf4a90b3a | 2025-11-17 | Warnings | XF417D3PSL |
| Antifungal cream | ANTIFUNGAL CREAM | Guangzhou Guoyoumi Biotechnology Co Ltd | 43a5b3c8-3b99-b113-e063-6394a90a9aff | 2025-11-15 | Warnings | PDC6A3C0OX |
| ondansetron hydrochloride | ONDANSETRON HYDROCHLORIDE | Onesource Specialty Pharma Limited | 438c3d28-8bed-50f0-e063-6394a90a18e4 | 2025-11-14 | Warnings, Adverse reactions | NMH84OZK2B |
| ondansetron hydrochloride | ONDANSETRON HYDROCHLORIDE | Onesource Specialty Pharma Limited | a5fe05bc-a7a5-4131-8c4d-2edd113441ec | 2025-11-14 | Warnings, Adverse reactions | NMH84OZK2B |
| Atti amour Rose Anti-Aging Repair Classic Essence | NIACINAMIDE, GLYCERIN | RIVER SUNZ co.,Ltd | 1e874ac0-a993-be9e-e063-6394a90af424 | 2025-11-06 | Warnings | PDC6A3C0OX |
| Atti amour Rose Anti-Aging Repair Eye Cream | NIACINAMIDE, GLYCERIN | RIVER SUNZ co.,Ltd | 1eeb9c36-5bd8-ec90-e063-6294a90ae4e1 | 2025-11-06 | Warnings | PDC6A3C0OX |
| Atti amour Rose Anti-Aging Repair Serum | NIACINAMIDE, GLYCERIN | RIVER SUNZ co.,Ltd | 1eb08f86-eb2a-7f29-e063-6294a90a0516 | 2025-11-06 | Warnings | PDC6A3C0OX |
| Atti amour Rose Anti-Aging Repair Moisturizing Cream | NIACINAMIDE, GLYCERIN | RIVER SUNZ co.,Ltd | 1eec4cfe-d5a3-3570-e063-6294a90ac38b | 2025-11-06 | Warnings | PDC6A3C0OX |
| Pranicura 5 | GLYCERIN, KAOLIN, CALAMINE, MENTHOL | Pranicura Products LLC | af520a58-3f3c-4d28-a41f-3ed8f74da095 | 2025-11-04 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2025-10-29 | Warnings | PDC6A3C0OX |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Publix Super Markets Inc | 354a640c-bc7e-45c8-9df0-8b5b01767f5c | 2025-10-29 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.